Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
Women who took oral contraceptives for three or more years are twice as likely to suffer from glaucoma, a leading cause of blindness, a U.S. researcher says. Lead researcher Dr. Shan Lin, a professor of clinical ophthalmology at the ...
Tags: long-term, user, oral, contraceptive, glaucoma test
Sometimes a regular digital camera has the potential to shed light on eye conditions. In the case of infant Noah Shaw, it may have been an early warning of cancer—and an advance in ophthalmology, according to a recent report in ...
Tags: Ophthalmology, Baby Photos, Popular Science
Canon U.S.A., Inc. will showcase its latest eye care technologies, including its new imageSPECTRUM (v5.0) Image Management System software, during the 2013 Annual Meeting of the American Academy of Ophthalmology (AAO), November 15-19, at ...
Tags: Canon USA, Eye Care Technologies
Oraya Therapeutics announced that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time ...
Tags: Oraya Therapeutics, Medicine
Fuse Science has announced further advancements of its technology partnership with Macular Health. Fuse Science is a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine ...
Tags: Fuse Science Technology, Medicine
Residents of major cities such as Chicago or New York with high levels of air pollution have an increased risk of dry eye syndrome, U.S. researchers say. Dr. Anat Galor of the Miami Veterans Affairs Medical Center, assistant professor of ...
Tags: dry, eye, air pollution, weather condition
US-based Escalon Medical has announced its plans to introduce a new tablet-based ultrasound imaging system, the Sonomed Escalon VuPad, at the upcoming 117th Annual Meeting of the American Academy of Ophthalmology (AAO), 16 November to 19 ...
Bayer has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). AMD, a progressive eye disease that ...
Tags: Wet AMD Patients, Bayer
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...
Tags: injectable drug, Innocore
Crash risks while driving at night are higher than during the daytime, but most roadways in the U.S. do not have roadway lighting. In fact, many state and local governments find it difficult to pay for installing, operating and maintaining ...
Biomedical engineers from The Johns Hopkins University have partnered with clinicians to create new therapeutic eye injections for a type of central vision loss caused by blood vessel growth at the back of the eye. The new drug, with a ...
Increasing demand for antimicrobials from end-user applications such as medical devices boosts the antimicrobial coatings market in Asia-Pacific. The need to minimize infection and in turn, the cost of treatment has spurred the use of ...